BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2952512)

  • 21. Histamine-releasing activity and binding to the FcepsilonRI alpha human mast cell receptor subunit of mast cell degranulating peptide analogues with alanine substitutions.
    Buku A; Mendlowitz M; Condie BA; Price JA
    J Med Chem; 2003 Jul; 46(14):3008-12. PubMed ID: 12825939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigen-dependent transition of IgE to a detergent-insoluble form is associated with reduced IgE receptor-dependent secretion from RBL-2H3 mast cells.
    Seagrave J; Oliver JM
    J Cell Physiol; 1990 Jul; 144(1):128-36. PubMed ID: 2142164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the target cell receptor for IgE. II. Polyacrylamide gel analysis of the surface IgE receptor from normal rat mast cells and from rat basophilic leukemia cells.
    Conrad DH; Froese A
    J Immunol; 1976 Feb; 116(2):319-26. PubMed ID: 1249417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Participation of the N-terminal region of Cepsilon3 in the binding of human IgE to its high-affinity receptor FcepsilonRI.
    Henry AJ; Cook JP; McDonnell JM; Mackay GA; Shi J; Sutton BJ; Gould HJ
    Biochemistry; 1997 Dec; 36(50):15568-78. PubMed ID: 9398285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conservation of signal transduction mechanisms via the human Fc epsilon RI alpha after transfection into a rat mast cell line, RBL 2H3.
    Gilfillan AM; Kado-Fong H; Wiggan GA; Hakimi J; Kent U; Kochan JP
    J Immunol; 1992 Oct; 149(7):2445-51. PubMed ID: 1382104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fine specificity, structure, and proteolytic susceptibility of the human lymphocyte receptor for IgE.
    Peterson LH; Conrad DH
    J Immunol; 1985 Oct; 135(4):2654-60. PubMed ID: 2411808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgE-mediated rat mast cell triggering with tryptic and synthetic peptides of bovine beta-lactoglobulin.
    Fritsché R; Adel-Patient K; Bernard H; Martin-Paschoud C; Schwarz C; Ah-Leung S; Wal JM
    Int Arch Allergy Immunol; 2005 Dec; 138(4):291-7. PubMed ID: 16220005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant human IgE.
    Gould HJ; Helm BA; Marsh PJ; Geha RS
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):392-3. PubMed ID: 2952601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Number and affinity of receptors for IgE on enriched populations of isolated rat intestinal mast cells.
    Lee TD; Sterk A; Ishizaka T; Bienenstock J; Befus AD
    Immunology; 1985 Jun; 55(2):363-6. PubMed ID: 3159653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-linking of IgE-receptor complexes at the cell surface: synthesis and characterization of a long bivalent hapten that is capable of triggering mast cells and rat basophilic leukemia cells.
    Kane P; Erickson J; Fewtrell C; Baird B; Holowka D
    Mol Immunol; 1986 Jul; 23(7):783-90. PubMed ID: 2948111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a mouse anti-rat IgE monoclonal antibody, 44.7b, which inhibits IgE binding to RBL cells.
    Rup BJ; Kahn LE
    Int Arch Allergy Appl Immunol; 1989; 89(4):387-93. PubMed ID: 2529219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding properties and histamine release in variants of rat basophilic leukemia cells with changes in the IgE receptor.
    Stracke ML; Basciano LK; Siraganian RP
    Immunol Lett; 1987 Apr; 14(4):287-92. PubMed ID: 2438212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein malnutrition: effect on rat peritoneal mast cell number, histamine content, and IgE receptors.
    Rickard AL; Lagunoff D
    Am J Clin Nutr; 1989 Apr; 49(4):641-5. PubMed ID: 2522733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of synthetic peptides in the production and characterization of antibodies directed against predetermined specificities in rat immunoglobulin E.
    Burt DS; Hastings GZ; Stanworth DR
    Mol Immunol; 1986 Feb; 23(2):181-91. PubMed ID: 3702875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design of a heterobivalent ligand to inhibit IgE clustering on mast cells.
    Handlogten MW; Kiziltepe T; Moustakas DT; Bilgiçer B
    Chem Biol; 2011 Sep; 18(9):1179-88. PubMed ID: 21944756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of non-antigen receptors in mast cell signalling processes.
    Stanworth DR
    Mol Immunol; 1984 Dec; 21(12):1183-90. PubMed ID: 6084173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies of the IgE binding sites to rat mast cell receptor with proteolytic fragments and with a monoclonal antibody directed against epsilon heavy chain: evidence that the combining sites are located in the C epsilon 3 domain.
    Rousseaux-Prevost R; Rousseaux J; Bazin H
    Mol Immunol; 1987 Feb; 24(2):187-96. PubMed ID: 2956498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The high-affinity receptor for immunoglobulin E. Prospects for the therapy of immediate hypersensitivity reactions.
    Dreskin SC; Metzger H
    JAMA; 1988 Sep; 260(9):1265-8. PubMed ID: 2841507
    [No Abstract]   [Full Text] [Related]  

  • 39. The high affinity receptor for IgE on mast cells.
    Metzger H
    Clin Exp Allergy; 1991 May; 21(3):269-79. PubMed ID: 1830826
    [No Abstract]   [Full Text] [Related]  

  • 40. IgE receptors from rat intestinal mucosal and peritoneal mast cells show mast cell subtype-specific differences.
    Swieter M; Chan BM; Lee TD; Rimmer CJ; Froese A; Befus D
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):200-2. PubMed ID: 2523356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.